The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...
Rifle city council met March 19 for their regular meeting for a variety of actions concerning grants, purchases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback